Evidence map›Paper›PMID 22965006›Full record

ArticleMolecular psychiatry2014

Predicting the diagnosis of autism spectrum disorder using gene pathway analysis.

E Skafidas, R Testa, D Zantomio, G Chana, I P Everall, C Pantelis

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.Journal of autism and developmental disorders · 2014
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Case Report: Clinical delineation ofFrontiers in neurology · 2023
    Article
  13. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  14. Pathophysiological Roles of Auxiliary Calcium Channel αHandbook of experimental pharmacology · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Inhibitory effects on L- and N-type calcium channels by a novel CaNaunyn-Schmiedeberg's archives of pharmacology · 2022
    Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

E SkafidasCentre for Neural Engineering, The University of Melbourne, Parkville, VIC, Australia.
R Testa1] Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, VIC, Australia [2] Department of Psychology, Monash University, Clayton, VIC, Australia.
D ZantomioDepartment of Haematology, Austin Health, Heidelberg, VIC, Australia.
G ChanaDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
I P EverallDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
C Pantelis1] Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, VIC, Australia [2] Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
University of Melbourne · AUAustin Health · AUMelbourne Health · AU

Funding

Center for Genomic and Phenomic Studies in AutismU24MH081810 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAJONCHERE, CLARA M · 2007 to 2011
$8.3M
Medical Research Council G1001799Medical Research Council G1234567NIMH NIH HHS 1U24MH081810NIMH NIH HHS U24 MH081810Wellcome TrustWellcome Trust 012345
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) depends on a clinical interview with no biomarkers to aid diagnosis. The current investigation interrogated single-nucleotide polymorphisms (SNPs) of individuals with ASD from the Autism Genetic Resource Exchange (AGRE) database. SNPs were mapped to Kyoto Encyclopedia of Genes and Genomes (KEGG)-derived pathways to identify affected cellular processes and develop a diagnostic test. This test was then applied to two independent samples from the Simons Foundation Autism Research Initiative (SFARI) and Wellcome Trust 1958 normal birth cohort (WTBC) for validation. Using AGRE SNP data from a Central European (CEU) cohort, we created a genetic diagnostic classifier consisting of 237 SNPs in 146 genes that correctly predicted ASD diagnosis in 85.6% of CEU cases. This classifier also predicted 84.3% of cases in an ethnically related Tuscan cohort; however, prediction was less accurate (56.4%) in a genetically dissimilar Han Chinese cohort (HAN). Eight SNPs in three genes (KCNMB4, GNAO1, GRM5) had the largest effect in the classifier with some acting as vulnerability SNPs, whereas others were protective. Prediction accuracy diminished as the number of SNPs analyzed in the model was decreased. Our diagnostic classifier correctly predicted ASD diagnosis with an accuracy of 71.7% in CEU individuals from the SFARI (ASD) and WTBC (controls) validation data sets. In conclusion, we have developed an accurate diagnostic test for a genetically homogeneous group to aid in early detection of ASD. While SNPs differ across ethnic groups, our pathway approach identified cellular processes common to ASD across ethnicities. Our results have wide implications for detection, intervention and prevention of ASD.

Indexed as

Asian PeopleChild Development Disorders, PervasiveCohort StudiesFemaleGene Regulatory NetworksGenetic Predisposition to DiseaseGenetic TestingGTP-Binding Protein alpha Subunits, Gi-GoHumansLarge-Conductance Calcium-Activated Potassium Channel beta SubunitsMaleNerve Tissue ProteinsPolymorphism, Single NucleotideReceptor, Metabotropic Glutamate 5White PeopleGNAO1 protein, humanGRM5 protein, humanGTP-Binding Protein alpha Subunits, Gi-GoKCNMB4 protein, humanLarge-Conductance Calcium-Activated Potassium Channel beta SubunitsNerve Tissue ProteinsReceptor, Metabotropic Glutamate 5

Identifiers

PMID22965006
PMCPMC3966080
OpenAlexW1997899395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.